Urinary bladder carcinogenesis with N-substituted aryl compounds: initiation and promotion

Area of Science:

• Toxicology
• Oncology
• Carcinogenesis

Background:

• Aromatic amines have been recognized as human bladder carcinogens since the late 19th century.
• Early research identified 2-naphthylamine and N-2-fluorenylacetamide as key carcinogens, leading to the development of rodent models.
• Subsequent discoveries introduced organ-specific rodent models for studying bladder cancer, such as those using N-butyl-N-(4-hydroxybutyl) nitrosamine.

Purpose of the Study:

• To review the historical context and evolution of bladder cancer research models.
• To examine the metabolic activation pathways of aromatic amines and amides.
• To explore the two-stage model of bladder carcinogenesis and the role of urine.

Main Methods:

• Historical review of etiological studies and carcinogen identification.
• Examination of metabolic activation pathways for aromatic amines and amides.
• Analysis of rodent models and their application in bladder cancer research.
• Investigation into the role of urine as a promoting agent and carrier of carcinogens.

Main Results:

• Aromatic amines are established human bladder carcinogens.
• Rodent models, including those using N-2-fluorenylacetamide and nitrosamines, have been crucial for studying bladder carcinogenesis.
• Bladder carcinogenesis can be modeled as a two-stage process, with potential promoters like sodium saccharin, sodium cyclamate, and tryptophan identified.
• Urine plays a dual role in bladder carcinogenesis, acting as both a promoter and a carrier of carcinogenic substances.

Conclusions:

• The study highlights the significant role of aromatic amines in bladder cancer etiology.
• Various experimental models have advanced the understanding of bladder cancer development.
• The two-stage initiation-promotion model and the influence of urine are critical factors in bladder carcinogenesis.